In these mice, administration of Toll-like receptor (TLR) ligands, including lipopolysaccharides (LPS) and poly(I:C), induces the development of MAS by mimicking an acute infection on a background of high levels of IL-6 [23]. Here, IL6 is linked to macrophage activation syndrome.